ESOR Special Focus Series
Lung Cancer Screening - 2
Lectures
1
The Radiologist’s Role in Lung Cancer Screening: From Image to Impact
30:00Annemiek Snoeckx
2
Uncovering more than nodules: parenchymal abnormalities in LCS participants
30:00Cornelia Schaefer-Prokop
3
Lung Cancer Screening: the UK’s longstanding experience and lessons learned
30:00David Baldwin
4
Lung Cancer Screening: The HANSE study experience
30:00Jens Vogel-Claussen
5
Communicating Results to Participants: tips and best practices
30:00Marie-Pierre Revel
6
AI in Lung Cancer Screening: Potential, Performance and Limitations
30:00Colins Jacobs
7
Ten years of Lung Cancer Screening participation in I-ELCAP
30:00Luis Seijo
8
Case-Based Session #2
30:00Roberta Ledda
COURSE INFORMATION
The Special Focus Series offers unique courses, tailored to address some of the most pressing topics for radiologists today.
The series includes both online and onsite courses, in a range of different formats.
From oncology and mental health to teaching skills and sustainability practices, the Special Focus Series aims to give you the skills modern radiologists need.
This advanced ESOR Special Course offers an in-depth exploration of lung cancer screening (LCS) across Europe and beyond. Through lectures by leading international experts, participants will gain a comprehensive understanding of current evidence, implementation strategies, and practical challenges in LCS. Combining scientific insight with real-world experience, the course equips radiologists with the tools to play an active role in screening programmes—enhancing early detection, patient communication, and multidisciplinary collaboration.
Attention: You need to attend both days to receive a CME certificate!
See here for more information.
LEARNING OBJECTIVES
-
Describe current eligibility criteria and international approaches to lung cancer screening.
-
Apply evidence-based strategies for nodule management and quality assurance in LCS.
-
Recognise additional thoracic and cardiovascular findings relevant to screening participants.
-
Evaluate the role and limitations of AI in lung cancer screening workflows.
-
Communicate screening results effectively and empathetically to participants.
PROGRAMME ONLINE
Tuesday, January 20, 2026
| 12:30 – 13:00 | The Radiologist’s Role in Lung Cancer Screening: From Image to Impact Annemiek Snoeckx, Antwerp/BL |
| 13:00 – 13:30 | Uncovering More Than Nodules: Parenchymal Abnormalities in LCS Participants Cornelia Schaefer-Prokop, Amersfoort/NL |
| 13:30 – 14:00 | Lung Cancer Screening: the UK’s Longstanding Experience and Lessons Learned David Baldwin, Nottingham/UK |
| 14:00 – 14:30 | Lung Cancer Screening: The HANSE Study Experience Jens Vogel-Claussen, Hannover/DE |
| 14:30 – 15:00 | Q&A Session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:00 | Communicating Results to Participants: Tips and Best Practices Marie-Pierre Revel, Paris/FR |
| 16:00 – 16:30 | AI in Lung Cancer Screening: Potential, Performance and Limitations Colin Jacobs, Nijmegen/NL |
| 16:30 – 17:00 | Ten Years of Lung Cancer Screening Participation in I-ELCAP Luis Seijo, Navarra/ES |
| 17:00 – 17:30 | Case-Based Session #2 Roberta Ledda, Parma/IT |
| 17:30 – 18:00 | Q&A Session |